← Back to Search

Anticholinergic medication

1 for Overactive Bladder

N/A
Waitlist Available
Led By Scott A Farrell, MD, FRCSC
Research Sponsored by IWK Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The purpose of this study is to assess the effects of caffeine reduction/elimination on urinary symptoms in women with overactive bladders and compare this therapeutic approach to anticholinergic therapy. We hope to show a reduction in symptoms with caffeine reduction and determine how effective caffeine reduction is compared to medication. If caffeine reduction is shown to be beneficial, women may be encouraged to use this strategy before resorting to medications.

Eligible Conditions
  • Overactive Bladder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Active Control
Group I: 1Active Control1 Intervention
Caffeine reduction through diet and beverage counselling
Group II: 2Active Control1 Intervention
Anticholinergic medication

Find a Location

Who is running the clinical trial?

IWK Health CentreLead Sponsor
126 Previous Clinical Trials
102,574 Total Patients Enrolled
Scott A Farrell, MD, FRCSCPrincipal InvestigatorIWK Health Centre
~0 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top